1. Tsutsui M, Shimokawa H, Morishita T, Nakashima Y, Yanagihara N. Development of genetically engineered mice lacking all nitric oxide synthases. J Pharmacol Sci (Review). 2006; 102: 147-154(IF 3.578)
  2. Tasaki H, Yamashita K, Tsutsui M, Kamezaki F, Kubara T, Tanaka S, Sasaguri Y, Adachi T, Nakashima Y. Heparin-released extracellular superoxide dismutase is reduced in patients with coronary artery atherosclerosis. Atherosclerosis. 2006; 187: 131-138 (IF 6.847)
  3. Takahashi K, Toyohira T, Ueno S, Tsutsui M, Yanagihara N. Capsaicin inhibits catecholamine secretion and synthesis by blocking Na+ and Ca2+ influx through a vanilloid receptor-independent pathway in bovine adrenal medullary cells. Naunyn Schmiedebergs Arch Pharmacol. 2006; 374(2): 107-116 (IF 3.0)
  4. Suda O, Tsutsui M, Morishita T, Horiuchi M, Nakata S, Kouzuma R, Okazaki M, Sumiyama-Fujinishi A, Mizuki T, Yanagihara N, Tasaki H, Nakashima Y. Long-term treatment with imidapril but not with nifedipine enhances plasma NOx concentration in patients with essential hypertension. J Pharmacol Sci. 2006; 101: 159-165 (IF 3.578)
  5. Akasaka S, Nomura M, Nishii H, Fujimoto N, Ueta Y, Tsutsui M, Shimokawa H, Yanagihara N, Matsumoto T. The hypothalamo-pituitary axis responses to lipopolysaccharide-induced endotoxemia in mice lacking inducible nitric oxide synthase. Brain Res. 2006; 1089(1): 1-9 (IF 3.610)
  6. Yanagihara N, Liu M, Toyohira Y, Tsutsui M, Ueno S, Shinohara Y, Takahashi K, Tanaka K. Stimulation of catecholamine synthesis through unique estrogen receptors in the bovine adrenomedullary plasma membrane by 17beta-estradiol. Biochem Biophys Res Commun. 2006; 339: 548-553 (IF 6.300)
  7. Tasaki H, Miyamoto M, Kubara T, Kamezaki F, Tanaka S, Yamashita K, Tsutsui M, Nakashima Y. Crossover trial of intensive monotherapy with atorvastatin and combined therapy with atorvastatin and colestimide for Japanese familial hypercholesterolemia. Circ J. 2006; 70(1): 14-20 (IF 3.350)
  8. Noguchi K, Matsuzaki T, Ojiri Y, Sakanashi M, Nakasone J, Sakanashi M. Prostacyclin causes splenic dilation and haematological change in dogs. Clin Exp Pharmacol Physiol. 2006; 33: 81-88. (IF 2.963)